View Chimerix, Inc.'s top competitors like CymaBay Therapeutics, Enzon Pharmaceuticals, and Loxo Oncology.
Loxo Oncology develops oncological drugs for well-defined patient groups, whose cancers share common genetic drivers.
Stamford, Connecticut, US
Private
$16.8M Revenue
http://www.loxooncology.com
SIGA is a leader in global health, developing medicines to prevent and treat emerging infectious diseases with high unmet medical needs. Infectious diseases pose an imminent and severe threat to global health that cannot be adequately addressed with vaccines alone. Smallpox, mpox, and other orthopoxviruses are particularly worrisome because they are highly infectious and deadly. We are developing best-in-class products to treat these infections in patients worldwide.
New York, New York, US
Public
$173M Revenue
http://www.siga.com
101 Employees
SIGA Ticker
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
Cranford, New Jersey, US
Public
$6M Revenue
http://www.enzon.com
130 Employees
ENZN Ticker
Top Chimerix, Inc. Employees
-
13 -
3
-
Lisa Croissant
National Sales Director at Chimerix, Inc.
Denver, CO, US25+ -
23
-
Lisa Croissant
Head of Sales at Chimerix, Inc.
Bennett, CO, US1 -
Erica Sumner
Director QA GMP at Chimerix, Inc.
Raleigh, NC, US23
Related Companies
G2Crowd Trusted
300K+
Plugin Users
